Manufacturing AbbVie opts for North Carolina to house $1.4bn manufacturing site pharminent April 23, 2026
Policy / Pricing FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars pharminent April 22, 2026
Market Access Medicare weight loss drug pilot on ice as insurers decline to contribute pharminent April 22, 2026
Clinical Data Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial pharminent April 22, 2026
Policy / Pricing Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients pharminent April 22, 2026
Clinical Data Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision pharminent April 22, 2026
M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies pharminent April 22, 2026
M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies pharminent April 22, 2026
Policy / Pricing Medicare obesity drug pilot extended after insurer pushback pharminent April 22, 2026
Clinical Data BioAge says early data suggest ‘best-in-class’ potential for inflammation drug pharminent April 21, 2026
M&A / Deals Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs pharminent April 21, 2026
Clinical Data Merck, Eisai’s Keytruda triplet fails to improve survival in kidney cancer pharminent April 21, 2026
Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data pharminent April 21, 2026
Clinical Data Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls pharminent April 21, 2026
Commercial The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground pharminent April 21, 2026
Pipeline Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine pharminent April 21, 2026
Regulatory Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy pharminent April 21, 2026
Regulatory Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy pharminent April 21, 2026
